Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CD_AACR
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CD_AACR
-
Prikvačeni tweet
The January issue of Cancer Discovery is now online! http://bit.ly/2t121Vf pic.twitter.com/bbHlU32OML
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchWatch Talimogene laherparepvec plus pembrolizumab is effective in#sarcoma in a phase II#ClinicalTrial@sloan_kettering@WeillCornell#immunotherapy http://bit.ly/31uFtcb pic.twitter.com/RiT3EUecmX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
Advances in the Treatment of Acute Myeloid
#Leukemia: New Drugs and New Challenges | http://bit.ly/2Ot1BP0 via@CD_AACR |@NicholasShortMD, Konopleva,@TapKadia,@GBorthakur, Ravandi, DiNardo, and@Daver_Leukemia of@MDAndersonNews@LeukemiaMDA.#endcancer#leusm#AMLHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
@ElizSMcKenna, executive editor, joins us@UMRogelCancer to talk to about@CD_AACR !pic.twitter.com/4CfVANUC0K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending
#NGI2020? Be sure to look for@TaliLev123! http://bit.ly/2UpCMHi pic.twitter.com/s5aVnKkPdg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
Very excited to share this important review in
@CD_AACR by@MaraShermanLab synthesizing all the recent discoveries on CAF heterogeneity in#PancreaticCancer!https://twitter.com/marashermanlab/status/1224426326515281920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
Today is
#WorldCancerDay
. The AACR is the authoritative source of information about advances in the causes, diagnosis, treatment and prevention of cancer.http://bit.ly/2UnPXsp pic.twitter.com/ZEmdanvZWTHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ResearchWatch Granule neuron precursor–derived astrocytes promote#medulloblastoma@hui_zong@UVA#BrainCancer http://bit.ly/2v0K21O pic.twitter.com/Nt4EDmS7yi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
State unlocked: Michigan - excited for my visit to
@UMRogelCancer!pic.twitter.com/4k80FftH9t
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
Pleasure to review CAF heterogeneity in
#PDAC@CD_AACR. Much more to learn, and exciting discoveries on the horizon (h/t@ednacukierman@shouval@Cosimo_Commisso@BiffiGiulia@ElyadaEla@claus_jorgensen@LyssiotisLab and the Twitter-free PDAC fibromaniacs)https://cancerdiscovery.aacrjournals.org/content/early/2020/02/02/2159-8290.CD-19-1353 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From the January issue: The first-in-human
#ClinicalTrial of#adenosine-pathway blockade for cancer#immunotherapy@lawfong@UCSF#A2AR#KidneyCancer http://bit.ly/3b7YWnz pic.twitter.com/78vIfcdG8j
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From the January issue: The
#KRASG12C inhibitor MRTX849 provides insight into therapeutic susceptibility of#KRAS-mutant cancers in mouse models and patients. http://bit.ly/2vNbMYb pic.twitter.com/MHdWeVi40r
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Associate Editor
@TaliLev123 is at#NGI2020- be sure to say hello! http://bit.ly/2GMz0Qx pic.twitter.com/VqleIVOMzo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
Pediatric cancer survivorship portal released. “We want to make this data accessible to as many types of scientific researchers & clinicians as possible." -Dr. Alex Gout, lead scientist of the St. Jude Cloud project. http://ow.ly/1gNT50y8ttn
#bioinformatics@CD_AACR@haloupekpic.twitter.com/pnVMTrJnSo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery News
#NotedthisWeek: A curated list of recent breaking news. http://bit.ly/38VSePv pic.twitter.com/k4MxWa3sHJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read this week’s Cancer Discovery
#ResearchWatch http://bit.ly/2UdWaqX pic.twitter.com/EV45dV6zv2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From the January issue: PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in
#BreastCancer@MGHCancerCenter@NovartisScience http://bit.ly/2ub0RXR pic.twitter.com/8Sab6CTDLd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Just published! Impaired death-receptor signaling in
#leukemia causes antigen-independent resistance by inducing CAR-T cell dysfunction@NathanSinghLab1@MarcoRuella@RuellaLab@PennMedicine@WUSTLmed#immunotherapy https://cancerdiscovery.aacrjournals.org/content/early/2020/01/24/2159-8290.CD-19-0813 …pic.twitter.com/HRBiQePGjT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
In this study, we discovered that impaired death receptor signaling in leukemia causes antigen-independent resistance to CAR T cells by causing T cell dysfunction.
@NathanSinghLab1@GillSaar@RuellaLab@carlhjune@PennMedicine@CD_AACR@NovartisNewshttps://cancerdiscovery.aacrjournals.org/content/early/2020/01/24/2159-8290.CD-19-0813 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cancer Discovery proslijedio/la je Tweet
So excited to share our paper from my time with
@carlhjune out now in@CD_AACR! Ton of collaborative work: thanks to@MarcoRuella, Saar Gill,@WeitzmanLab,@NovartisScience and others@PennMedicine. Check it out!https://cancerdiscovery.aacrjournals.org/content/early/2020/01/24/2159-8290.CD-19-0813 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From the January issue: PTEN loss mediates clinical cross-resistance to CDK4/6 and PI3Kα inhibitors in
#BreastCancer@MGHCancerCenter@NovartisScience https://cancerdiscovery.aacrjournals.org/content/10/1/72 pic.twitter.com/y1ygS5VdpZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.